Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy
REV BRAS FARMACOGN
ISSN / eISSN
0102-695X / 1981-528X
Aims and Scope
The Brazilian Journal of Pharmacognosy is a scientific journal edited and published by the Brazilian Society of Pharmacognosy, an association that brings together researchers, students and professionals who study and investigate the physical, chemical and biological drugs, especially those of vegetable origin, substances isolated and such as the potential source of drugs of natural origin. It is available in printed form for its members and subscribers and openly on the Internet in all your numbers and content. The articles published are original research contributions. To evaluate the work use is made of international standards and is held by the ad hoc advisers, which reflects the quality and credibility of the journal. The BJP is published since 1986.
Subject Area
CHEMISTRY, MEDICINAL
PHARMACOLOGY & PHARMACY
CiteScore
4.00
View Trend
CiteScore Ranking
| Category | Quartile | Rank |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics - General Pharmacology, Toxicology and Pharmaceutics | Q1 | #20/79 |
Web of Science Core Collection
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| Category (Journal Citation Reports 2023) | Quartile |
|---|---|
| CHEMISTRY, MEDICINAL - SCIE | Q4 |
| PHARMACOLOGY & PHARMACY - SCIE | Q4 |
Country/Area of Publication
BRAZIL
Publisher
Springer International Publishing
Publication Frequency
6 issues per year
Year Publication Started
2015
Annual Article Volume
126
Open Access
YES
Contact
CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started